A novel Wiskott-Aldrich syndrome protein mutation in an infant with thrombotic thrombocytopenic purpura

European Journal of Haematology

Volumn 90, Issue 2, 2013, Pages 164-168

  Kawasaki, Yukako ^a   Toyoda, Hidemi ^a   Otsuki, Shoichiro ^a   Iwasa, Tadashi ^a   Iwamoto, Shotaro ^a   Azuma, Eiichi ^a   Itoh Habe, Naomi ^a   Wada, Hideo ^a   Fujimura, Yoshihiro ^b   Morio, Tomohiro ^c   Imai, Kohsuke ^d   Mitsuiki, Noriko ^c,e   Ohara, Osamu ^e   Komada, Yoshihiro ^a  

^a MIE UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^e KAZUSA DNA RESEARCH INSTITUTE   (Japan)

Author keywords

Autoimmunity; Thrombotic thrombocytopenic purpura; Wiskott Aldrich syndrome

Indexed keywords

GANCICLOVIR; GENOMIC DNA; IMMUNOGLOBULIN; PREDNISONE; STEROID; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; BLOOD SMEAR; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FLOW CYTOMETRY; FRAMESHIFT MUTATION; GENE DELETION; HUMAN; INFANT; MALE; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOP CODON; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; URINALYSIS; VIREMIA; VIRUS GENOME; WESTERN BLOTTING; WISKOTT ALDRICH SYNDROME;

ADAM PROTEINS; AUTOANTIBODIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EXONS; GENETIC DISEASES, X-LINKED; HUMANS; INDEL MUTATION; INFANT; MALE; PLASMA EXCHANGE; PLATELET TRANSFUSION; PURPURA, THROMBOTIC THROMBOCYTOPENIC; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 84872824446     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12057     Document Type: Article

References (25)

1. Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 2009;113:6288-95.
2. Zhu Q, Watanabe C, Liu T, Hollenbaugh D, Blaese RM, Kanner SB, Aruffo A, Ochs HD. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood 1997;90:2680-9.
3. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006;117:725-38.
4. Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 2004;104:4010-9.
5. Albert MH, Bittner TC, Nonoyama S, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood 2010;115:3231-8.
6. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD, Nonoyama S. Clinical course of patients with WASP gene mutations. Blood 2004;103:456-64.
7. Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant 2009;15:84-90.
8. Catucci M, Castiello MC, Pala F, Bosticardo M, Villa A. Autoimmunity in Wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol 2012;3: Article 209: 1-14.
9. Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 2003;111:e622-7.
10. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001;98:1662-6.
11. Rieger M, Mannucci PM, Kremer Hovinga JA, et al. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood 2005;106:1262-7.
12. Kawai S, Minegishi M, Ohashi Y, et al. Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulations. J Immunol Methods 2002;260:195-205.
13. Kasper CK, Pool JG. Letter: measurement of mild factor VIII inhibitors in Bethesda units. Thromb Diath Haemorrh 1975;34:875-6.
14. Kato S, Matsumoto M, Matsuyama T, Isonishi A, Hiura H, Fujimura Y. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion 2006;46:1444-52.
15. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994;78:635-44.
16. Konno A, Kirby M, Anderson SA, Schwartzberg PL, Candotti F. The expression of Wiskott-Aldrich syndrome protein (WASP) is dependent onWASP-interacting protein (WIP). Int Immunol 2007;19:185-92.
17. Welch MD, Mullins RD. Cellular control of actin nucleation. Annu Rev Cell Dev Biol 2002;18:247-88.
18. Cleland SY, Siegel RM. Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases. FEBS Lett 2011;585:3710-4.
19. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994;125:876-85.
20. Doherty M, Bradfield JW. Polyarteritis nodosa associated with acute cytomegalovirus infection. Ann Rheum Dis 1981;40:419-21.
21. Ramasubbu K, Mullick T, Koo A, Hussein M, Henderson JM, Mullen KD, Avery RK. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl Infect Dis 2003;5:98-103.
22. Matsuyama T, Kuwana M, Matsumoto M, Isonishi A, Inokuma S, Fujimura Y. Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Thromb Haemost 2009;102:371-8.
23. Monteferrante G, Giani M, van den Heuvel M. Systemic lupus erythematosus and Wiskott-Aldrich syndrome in an Italian patient. Lupus 2009;18:273-7.
24. Nikolov NP, Shimizu M, Cleland S, Bailey D, Aoki J, Strom T, Schwartzberg PL, Candotti F, Siegel RM. Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein. Blood 2010;116:740-7.
25. Humblet-Baron S, Sather B, Anover S, et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest 2007;117:407-18.